Canopy Growth Corporation (CGC) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 11, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the DEF 14A for FY2026, filed Aug 7, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CGC SEC filings page.
This page shows Canopy Growth Corporation (CGC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Persistent net losses and a volatile share count dominate the record, while operating performance remains unobservable from the supplied figures.
Total loss narrowed from-$2.42B in FY2023 to-$189M in FY2026, but that improvement is not enough to establish healthier per-share economics. Shares outstanding swung from 586.6M in FY2023 to 422.2M in FY2026, after an intervening low point, so total-loss comparisons need a share-base lens.
Every reported annual row remains loss-making, with the latest loss smaller than FY2025's
Some figures from recent filings were inconsistent and were omitted from this summary.
Financial Health Signals
Canopy Growth Corporation does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The metrics below are current.
Key Financial Metrics
Earnings & Revenue
Canopy Growth Corporation reported -$189.0M in net income in fiscal year 2026. This represents an increase of 46.6% from the prior year.
Not reported for fiscal year 2026.
Not reported for fiscal year 2026.
Not reported for fiscal year 2026.
Cash & Balance Sheet
Not reported for fiscal year 2026.
Not reported for fiscal year 2026.
Not reported for fiscal year 2026.
Margins & Returns
None of these metrics is reported for fiscal year 2026.
Capital Allocation
None of these metrics is reported for fiscal year 2026.
CGC Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, EPS (Basic), EPS (Diluted).
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Canopy Growth Corporation CGC | FY2026 | N/A | -$189.0M | N/A | $417.8M | — |
| Evolus, Inc. EOLS | FY2025 | $297.2M | -$51.6M | -17.4% | $517.8M | 34/100 |
| Kamada Ltd KMDA | FY2025 | $180.5M | $20.2M | 11.2% | $457.1M | 41/100 |
| Emergent Biosolutions, Inc. EBS | FY2025 | $742.9M | $52.6M | 7.1% | $319.4M | 36/100 |
| Eton Pharmaceutcials, Inc. ETON | FY2025 | $80.0M | -$4.6M | -5.8% | $1.6B | 50/100 |
| SIGA Technologies, Inc. SIGA | FY2025 | $94.6M | $23.3M | 24.6% | $217.7M | 59/100 |
Where Canopy Growth Corporation Ranks
Frequently Asked Questions
Is Canopy Growth Corporation profitable?
No, Canopy Growth Corporation (CGC) reported a net income of -$189.0M in fiscal year 2026.
What is Canopy Growth Corporation's P/E ratio?
Canopy Growth Corporation (CGC) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2026). The market capitalization is $417.8M as of Sep 11, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Canopy Growth Corporation's price-to-sales ratio?
Canopy Growth Corporation (CGC) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $417.8M as of Sep 11, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.